A biotech’s binary bet ends badly
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Category: Pharmaceuticals
.jpg)
FDA offers new guidelines for Covid-19 vaccine
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Under pressure to thwart pharma patent abuse, the PTO proposes a new rule. But will it fly?
In a bid to prevent the patent system from being abused, the U.S. Patent and…
STAT+: Colorado state board decides a pricey Novartis medicine is unaffordable
A blockbuster arthritis drug from Novartis may face a limit on what Colorado health plans…
STAT+: Pharmalittle: We’re reading about abortion pill access, employer coverage of GLP-1 drugs and more
And so, another working week will soon draw to a close. Not a moment too…
Biopharma execs cheer Supreme Court for upholding FDA authority in abortion pill case
On Thursday, the Supreme Court rejected an effort by anti-abortion doctors to bar the mailing…
With Avidity and Pfizer, gene therapy enters a phase
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Biden and Trump are fighting to claim credit for $35 insulin. It was actually a pharma giant’s idea
WASHINGTON — Both President Biden and former President Trump love to claim credit for getting…
STAT+: Europe is set to shake up the way it assesses new medicines. Gene therapy makers are worried
LONDON — A major shakeup in how the benefits of medicines are assessed in Europe…
What do Parkinson’s and obesity have in common?
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Watch: How pharmacy benefit managers influence drug pricing
This is Part 2 of “Behind the Counter,” an in-depth video series demystifying the complex…
Watch: The role of PBMs, patents, and public health in drug pricing
This is Part 1 of “Behind the Counter,” an in-depth video series demystifying the complex…
Bernie Sanders calls vote to subpoena Novo Nordisk U.S. head over Ozempic, Wegovy prices
WASHINGTON — Senate health committee chair Bernie Sanders has called a vote to subpoena the…
Eli Lilly’s Alzheimer’s candidate, Bob Langer’s new startup, and other biotech news you need to know
Want to stay on top of the science and politics driving biotech today? Sign up to get…
FDA expands approval for GSK’s RSV vaccine to cover younger at-risk adults
The Food and Drug Administration on Friday expanded the approval for GSK’s vaccine to protect…
Vanda Pharmaceuticals has another suitor
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Opinion: Obesity drugs pose a big challenge for health care equity
Weight loss treatments have the potential to revolutionize health care in rich countries. They are…
STAT+: At BIO, signs Congress’ tough stance on China is chilling biotech relationships
SAN DIEGO — U.S. legislation that seeks to restrict American biotechs from working with certain Chinese…
Novovax will be able to supply Covid-19 vaccines this fall
Want to stay on top of the science and politics driving biotech today? Sign up to get…
.jpg)
Withdrawal symptoms hit one in six patients stopping antidepressants, review finds
The moment when a person stops taking their antidepressant is fraught. Not only can patients…
Testing begins for a new form of PrEP
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Gilead to pay $40 million to settle claims it delayed newer HIV treatment to boost profits
Gilead Sciences agreed in principle to pay $40 million to more than 2,600 AIDS patients…
ASCO Takeaways: Winners, snoozers, the China question and the art of cancer care
You’re reading the web edition of ASCO in 30 Seconds, STAT’s guide to the American…
Senators tussle over abortion policy against the backdrop of a presidential campaign
WASHINGTON — Nearly two years after the Supreme Court overturned Roe v. Wade, U.S. senators on…
STAT+: U.S. drug shortages have reached a decade high and are lasting longer, too
Amid rising concern over prescription drug shortages, a new report finds that the number of…
Operation Warp Speed but for rare disease
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: At ASCO, AstraZeneca says its CAR-T therapy shrank solid liver tumors in early trial
CHICAGO — A next-generation CAR-T therapy was able to substantially shrink tumors in patients with…
Can AstraZeneca make good on its promise?
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: ASCO 2024: Data put a new shine on GSK blood cancer drug that was pulled from market
LONDON — The resurrection of a GSK blood cancer drug — which the company withdrew…
STAT+: ASCO Daily Recap: Safety data for Novartis myelofibrosis candidate, survival data for Pfizer drug
You’re reading the web edition of ASCO in 30 Seconds, STAT’s guide to the American…
STAT+: At ASCO, pharma leaders explain how ‘smart bomb’ drugs became useful against more cancers
CHICAGO — The ways clinicians can treat cancers effectively are expanding, partly because technologies today…
The surprising outperformance of a new drug against existing competitors, and other biotech updates
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Novartis sues Maryland over the role of contract pharmacies in a U.S. drug discount program
Novartis has filed a lawsuit seeking to block a Maryland law that requires the company…
STAT+: Many docs who tweeted product endorsements also took money from manufacturers, analysis shows
Most physicians who endorsed a prescription drug or medical device on X — formerly known…
Biohaven’s autoimmune drug disappoints, and other biotech news updates from the week
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Wegovy linked to lower risk of alcohol use disorder in real-world study
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Reports: Looking to expand its pipeline, Merck to buy eye-disease startup EyeBio
LONDON — Merck is buying ophthalmology-focused startup EyeBio in a deal worth up to $3…
Black voices, Black bodies: Life in the age of Ozempic
STAT teamed up with Word In Black, a network of 10 Black news publishers, to…
Biotech’s most interesting fundraisings from the last week
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Airway disease drug from Insmed succeeds in one of the year’s most anticipated trials
An experimental drug from Insmed Incorporated successfully reduced lung problems among patients with an airway…
STAT+: Duchenne muscular dystrophy drug from Nippon Shinyaku fails in rare confirmatory trial
Japanese drugmaker Nippon Shinyaku said on Monday that its Duchenne muscular dystrophy drug, Viltepso, part…
More tumult at BIO amid the company’s fourth CEO in four years
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Pharma’s losing bet in New Jersey
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…
Listen: More tumult at BIO & coercive care for sickle cell patients
How does a drug industry lobbying group move forward after years of upheaval, including having…
In light of H5N1 outbreak, U.S. in talks with mRNA vaccine makers on bird flu
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Biotechs turn to gene silencing for obesity drugs that can last longer than Wegovy
Enticed by the immense market opened by GLP-1 weight loss drugs Wegovy and Zepbound, a…
STAT+: FDA poised to publish guidelines for clinical trial diversity
The Food and Drug Administration is poised to tell drug and medical device makers how…
STAT+: New antiviral works against coronaviruses in mice, but human testing will have to wait
During the Covid-19 pandemic, vaccines were the main line of defense. Startlingly effective shots quickly…
Maryland takes first steps to cap drug costs
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Off-label treatment for alcohol use disorder is linked to slower liver decline, study suggests
WASHINGTON — There are three FDA-approved drugs for treating alcohol use disorder. But a different…